Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Department of Family Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Br J Clin Pharmacol. 2018 Nov;84(11):2678-2682. doi: 10.1111/bcp.13737. Epub 2018 Aug 29.
An 87-year-old woman with a long-standing history of hypertension, hypothyroidism and diabetes presented to us with scaly and pruritic vesicles of an erythematous base and crusted surface of 2-month duration. They first appeared on her abdomen and gradually spread to her lower back, thighs, before spreading to her upper and lower limbs. Her lesions were non-painful, aggravated by sun exposure only, and sparing mucous membranes. Nikolsky sign was positive with no discernible fluid-filled bullae. History was remarkable only for a doubling of her Lisinopril dosage 2 months prior to the appearance of her lesions, with no other potential environmental and/or drug triggers recognizable on history taking. In light of the appearance of her lesions after her Lisinopril dose escalation, in the absence of any other discernible triggers, an adverse drug reaction (ADR) was entertained, yielding a corresponding Naranjo ADR probability score of 7. Particularly, drug-induced pemphigus foliaceus was initially suspected given her clinical presentation and the morphology and distribution of her lesions. However, her skin biopsy altered our diagnosis to drug-induced bullous pemphigoid (BP) instead, making this the second case reported to date on Lisinopril-induced BP, and the first to report a dose-response variant of this adverse reaction.
一位 87 岁的女性,有长期高血压、甲状腺功能减退和糖尿病病史,因红斑基础上有鳞屑和瘙痒性水疱,病程 2 个月,前来就诊。这些水疱最初出现在她的腹部,逐渐蔓延到她的下背部和大腿,然后扩散到她的上下肢。她的皮损无痛,仅在暴露于阳光下时加重,不累及黏膜。尼氏征阳性,未见明显充满液体的大疱。病史中唯一显著的是在皮损出现前 2 个月她的赖诺普利剂量增加了一倍,但在病史询问中没有发现其他潜在的环境和/或药物诱因。鉴于她在赖诺普利剂量增加后出现皮损,且没有其他明显的诱因,考虑为药物不良反应(ADR),相应的 Naranjo ADR 概率评分为 7。特别是,鉴于她的临床表现以及皮损的形态和分布,最初怀疑为药物诱导性类天疱疮。然而,她的皮肤活检改变了我们的诊断,提示为药物诱导性大疱性类天疱疮(BP),这是迄今为止第二例赖诺普利诱导 BP 的报告,也是首例报告这种不良反应的剂量反应变异型。